Jason Fodeman

Extra medical visits will culminate in additional health care costs. This law could also push some doctors to order more expensive trade-name drugs, which would exacerbate the impact on health care costs.

In fact the provision undercuts the very purpose of these consumer-driven plans. Their goal is to empower patients to shop around and become smarter health care consumers. Data shows they do in fact work. Yet, this legislation throws a monkey wrench in their success. It makes them more cumbersome and less attractive to patients. Unfortunately, more restrictions with these popular accounts are in the works. The new law puts them on a trajectory to oblivion, which is consistent with the administration’s vision of a one-size fits-all medical system regulated by bureaucrats.

In outlining a new regulatory review, President Obama recently wrote “we are also making it our mission to root out regulations that conflict, that are not worth the cost, or that are just plain dumb.” If the President is truly serious about this objective, perhaps the 1,000’s of pages of regulations emanating from ObamaCare would be a good place to start.

Jason Fodeman

Jason D. Fodeman, M.D. is an Internal Medicine Resident at UCONN and a former health policy fellow at the Heritage Foundation.